These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Annual usage in a general hospital of antimicrobials and frequency of resistant bacterial strains (author's transl)]. Cainarca M; Della Pietra A; Mauri A; Tamborini T; Vernocchi L Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():756-69. PubMed ID: 555536 [TBL] [Abstract][Full Text] [Related]
23. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]. Baquero F; Cercenado E; Cisterna R; de la Rosa M; García-Rodríguez JA; Gobernado M; Pérez JL; Manchado P; Martín R; Pascual A; Picazo J; Prats G; Rubio C; Snyder TA; Sanz-Rodríguez C Rev Esp Quimioter; 2006 Mar; 19(1):51-9. PubMed ID: 16688292 [TBL] [Abstract][Full Text] [Related]
24. [Extrachromosomal resistance in enterobacteria isolated from hospital infections]. García Rodríguez JA; Prieto Prieto J; Rodrigo Sánchez N; Sáenz González MC Rev Clin Esp; 1983 Jan; 168(2):113-6. PubMed ID: 6856897 [No Abstract] [Full Text] [Related]
25. [Raoultella ornithinolytica in urinary tract infections. Clinical and microbiological study of a series of 4 oncologic patients]. García-Lozano T; Pascual Plá FJ; Aznar Oroval E Med Clin (Barc); 2013 Aug; 141(3):138-9. PubMed ID: 23332629 [No Abstract] [Full Text] [Related]
26. Outcomes of Fosfomycin Use in Ceftriaxone-Resistant Enterobacteriaceae Urinary Tract Infection in the Elderly. Quek WM; Teng CB; Tan YZ; Chong K; Lye DC; Ng TM Int J Antimicrob Agents; 2019 Feb; 53(2):195-196. PubMed ID: 30722963 [No Abstract] [Full Text] [Related]
28. Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae. Bunnell KL; Wenzler E; Harrington AT; Danziger LH Diagn Microbiol Infect Dis; 2018 Apr; 90(4):335-336. PubMed ID: 29395714 [TBL] [Abstract][Full Text] [Related]
29. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report. Kahlmeter G J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():15-22; discussion 63-5. PubMed ID: 11051619 [TBL] [Abstract][Full Text] [Related]
30. Transferable antibiotic resistance in enterobacteriaceae isolated from urinary tract infections in general practice. Poston SM; Maclaren DM; Thornton VG Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):326-33. PubMed ID: 352037 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and sensitivity to antibiotics of Enterobacteriaceae isolated from urinary cultures in some microbiology laboratories of a city in west Greece. Papapetropoulou M; Pagonopoulou O; Kouskouni E Pathol Biol (Paris); 1997 Nov; 45(9):716-20. PubMed ID: 9538469 [TBL] [Abstract][Full Text] [Related]
32. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004). Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140 [TBL] [Abstract][Full Text] [Related]
33. [Prevalence of ESBL strains in urinary tract infections in children in 1996 and 2004]. Delińska-Galińska A; Kurlenda J; Kozielska E; Borkowska A; Luczak G; Plata-Nazar K Przegl Epidemiol; 2006; 60(1):59-64. PubMed ID: 16758740 [TBL] [Abstract][Full Text] [Related]
34. Fluoroquinolones for urinary tract infection and within-household spread of resistant Enterobacteriaceae: the smoking gun. Trautner BW Clin Microbiol Infect; 2018 Sep; 24(9):929-930. PubMed ID: 29649605 [No Abstract] [Full Text] [Related]
36. Incidence of resistance transfer factor (R factor) among enterobacteriaceae in urinary tract infections. Panse MV; Wadhwa KM Indian J Med Res; 1973 Nov; 61(11):1594-9. PubMed ID: 4791505 [No Abstract] [Full Text] [Related]
37. [In vitro sensitivity of gram-negative bacteria isolated from urinary tract infections to various antibiotics]. Kiliç H; Karahan M Mikrobiyol Bul; 1991 Jan; 25(1):28-35. PubMed ID: 1881356 [TBL] [Abstract][Full Text] [Related]
38. Bacteriology and antibiotic resistance pattern in community acquired urinary tract infection. Sharan R; Kumar D; Mukherjee B Indian Pediatr; 2013 Jul; 50(7):707. PubMed ID: 23942441 [TBL] [Abstract][Full Text] [Related]
39. Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection. Rieger KL; Bosso JA; MacVane SH; Temple Z; Wahlquist A; Bohm N Pharmacotherapy; 2017 Nov; 37(11):1479-1483. PubMed ID: 28869655 [TBL] [Abstract][Full Text] [Related]
40. [Multiple drug resistance and R-factors in enteric bacteria from clinical material]. Aandahl EH Tidsskr Nor Laegeforen; 1968 Sep; 88(18):1673-6. PubMed ID: 5705683 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]